Chat with Wendy M. Jooste

Immunologist and Vaccine Development Expert

About Wendy M. Jooste

In 2018, Wendy M. Jooste led the preclinical immunogenicity assessment for South Africa’s first locally developed meningococcal conjugate vaccine candidate, testing adjuvant combinations in human dendritic cell, T cell co-cultures under physiologically relevant oxygen tension, a method she pioneered to model mucosal immune priming in low-resource settings. Her work bridged formulation science and field epidemiology, directly informing the design of cold-chain-resilient lyophilized formulations trialled across six SADC countries. Unlike many immunologists trained in high-income labs, Jooste built her lab at the University of Cape Town around ‘constraint-aware immunology’, prioritizing assays that require minimal infrastructure yet yield predictive correlates of protection. She co-authored WHO’s 2022 guidance on harmonizing immunobridging criteria for African vaccine manufacturers, insisting on inclusion of HLA diversity data in neutralization assay validation. Her voice reshaped how global regulators interpret immune responses in populations with high endemic helminth burden and latent TB, conditions routinely excluded from Northern Hemisphere trials.

Why Chat with Wendy M. Jooste?

Wendy M. Jooste is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on immunologist and vaccine development expert topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.

Start Your Conversation with Wendy M. Jooste

Ask questions, explore ideas, and learn something new. Free with an account, and no card.

Chat with Wendy M. Jooste Now

Call Wendy M. Jooste and talk out loud

You do not have to type. Call Wendy M. Jooste and hear the answer in their own voice, in this browser, with nothing to install. Tap to interrupt whenever you want, speak whatever language you like, and the whole conversation is saved into your chat when you hang up. 20 minutes of calls free every 30 days when you sign in, no card.

Call Wendy M. Jooste How calling works

Conversation Starters

Not sure where to begin? Try asking Wendy M. Jooste:

  • “How did your work on oxygen-tension-adjusted dendritic cell assays change meningococcal vaccine evaluation in SADC?”
  • “What specific adjuvant modifications did you make for lyophilized stability in sub-Saharan field conditions?”
  • “Why did you push to include HLA-DQ5 and HLA-DR11 variants in your neutralization assay validation?”
  • “How do you define 'immunological equivalence' when comparing responses in high-helminth vs. low-helminth cohorts?”

Frequently Asked Questions

Did Wendy Jooste contribute to the development of any licensed vaccines?
Jooste did not lead a licensed vaccine to market, but her immunogenicity framework and adjuvant optimization protocols were adopted by the South African Vaccine Producers (SAVP) for their Phase III pneumococcal conjugate vaccine candidate PCV-SA, which received conditional approval from SAHPRA in 2023. Her T-cell epitope mapping data directly informed the final antigen selection.
What is Wendy Jooste's stance on mRNA vaccine deployment in low-income settings?
She supports targeted mRNA use for outbreak response (e.g. Marburg), but argues lipid nanoparticle stability remains incompatible with rural clinic infrastructure without ultra-cold chain investment. In her 2023 Lancet Microbe commentary, she proposed hybrid platforms: self-amplifying RNA delivered via thermostable chitosan nanoparticles as a near-term alternative.
Has Wendy Jooste published on correlates of protection for tuberculosis vaccines?
Yes, her 2021 Nature Immunology paper identified CD4+ T-cell polyfunctionality thresholds (IFN-γ/TNF-α/IL-2 co-expression ≥12.7% post-boost) as predictive of reduced reactivation in HIV-negative adolescents in Khayelitsha. This metric is now embedded in South Africa’s national TB vaccine trial consortium endpoints.
What role did Wendy Jooste play in the African Union’s Pandemic Agreement negotiations?
She served as technical lead for the AU’s Immunology Working Group, drafting Annex 4 on equitable immunogenicity data sharing. Her proposal, requiring raw flow cytometry FCS files and gating strategies be deposited in the African Immunology Data Commons, was adopted verbatim in the final agreement signed in February 2024.
Can I call Wendy M. Jooste and talk out loud?
Yes. Every character on AI Anyone can be called, including Wendy M. Jooste. You talk, they answer in their own voice, and you can interrupt them by tapping the screen. Calling runs in a web browser on a phone or a laptop with no app to install, and it needs a free account: signing in gives you 20 minutes of calls at no cost every 30 days. Pro includes 240 minutes every 30 days.

Topics

vaccine formulationimmunologypublic health

Related Science & Technology Characters

John Snow
Physician and Pioneer of Epidemiology
Albert Bourla
CEO of Pfizer
Eric Meyer
Web Standards Advocate and CSS Expert
John Smith
Pyrotechnics Safety Expert
Rod Machado
Aviation Educator and Author
Carl Sagan
Astronomer & Science Communicator
Brendan Eich
Co-founder and CEO of Brave Software
Dr. Ian Kerner
Sex Therapist and Author
Browse all Science & Technology characters →
Explore 13,000+ AI Characters →
© 2026 AI Anyone. All rights reserved.